New York, May 31, 2016 -- Moody's Investors Service, ("Moody's") last week affirmed Thermo Fisher Scientific Inc.'s Baa3 senior unsecured and Prime-3 short term ratings following the company's announced debt financed acquisition of FEI Company for $4.2 billion. The acquisition will expand Thermo Fisher's offerings within the company's Analytical Instruments segment. The FEI product lines are complementary to Thermo Fisher's mass spectrometry systems. The closing of the acquisition, which is subject to customary regulatory approvals, is expected to occur in early 2017. The rating outlook is positive.

Vollständigen Artikel bei Moodys lesen